| Alternative name 1: |
70kD, CD55, Clone: BRIC110, Decay Accelerating Factor (DAF), Mab anti-Human, Complement Regulatory Protein |
| Alternative name 2: |
70kD, CD55, Clone: BRIC110, Decay Accelerating Factor (DAF), Mab antibody-Human, Complement Regulatory Protein |
| Alternative name 3: |
70kD, CD55, Clone: BRIC110, Decay AcceleRattus norvegicusing Factor (DAF), Mab antibody-Homo sapiens, Complement Regulatory Protein |
| Alternative name 4: |
anti-Complement Regulatory Protein CD55 Decay Accele ing Factor DAF 70kD Clone: BRIC110 |
| Alternative name 5: |
Complement Regulatory Protein CD55 Decay Accele ing Factor DAF 70kD Clone: BRIC110 |
| Clonality: |
Monoclonal Antibody |
| Description: |
Amongst the advantages of the monoclonal antibodies are: the fact that while the hybridoma takes a bit longer to be produced, If used correctly and according the protocol, in comparison to the polyclonal antibodies monoclonal antibodies are highly specific to a given epitope and can be used in applications where specific targeting is required, once the line is ready there is virtually an endless supply of these antibodie throughout time with little to no variations in recognition sites of the antigen in different batches, this antibody will provide excellent and reproducible results with guaranteed success for the tested and confirmed applications, This is a monoclonal antibody which is greatly purified and with high binding affinity for the antigen that it is risen against |
| Storage and handling: |
Antibodies in a liquid form can be shipped and stored for a short period of time at +4 degrees Celsius, antibodies that are lyophilized can be transported at ambient temperature and stored for short terms at +4 degrees Celsius, for long term storage (up to one year) 25-50% glycerol or ethylene glycol should be added and then the container has to be stored at -20°, for longer periods - at -20 , C, Generally |
| Advisory: |
For antibodies in a liquid form or reconstituted lyophilized antibodies small amounts of the soultion could be captured on the cap or the walls of the container, Right before use you could briefly centrifuge the vial to collect all of the solution on the bottom, To keep the quality and the affinity of the antibody cycles of freezing and thawing should be avoided |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| About: |
Each murine monoclonal anibody has his own affinity specific for the clone, Mouse monoclonal antibodies are purified protein A or G and can be conjugated to FITC for flow cytometry or FACS and can be of different isotypes, Monoclonals of this antigen are available in different clones |
| Test: |
A/J, BALB/c, Mouse are mature after 40 days for females and 55 days for males, SCID while the CD-1 is outbred as strain, The female mice are pregnant only 20 days and can give birth to 10 litters of 6-8 mice a year, Transgenic, congenic and inbread strains are known for C57BL/6, knock-out, Mouse , mice from the Mus musculus species are used for production of mouse monoclonal antibodies or mabs and as research model for humans in your lab, or |
| Latin name: |
Mus musculus |
| French translation: |
anticorps |
| Gene target: |
BRIC110, CD55, Decay Accelerating Factor (DAF) 70kD, Monoclonal, Complement Regulatory Protein |
| Short name: |
CD55, Clone: BRIC110, Decay Accelerating Factor (DAF) 70kD, Mouse Monoclonal antibody-, Complement Regulatory Protein |
| Technique: |
Monoclonals or monoclonal antibodies, mouses, Mouse |
| Species: |
Humans, Mouses, Human |
| Alternative name: |
70kD, CD55 molecule, Decay Accelerating Factor (DAF), Mouse monoclonal (Antibody to)-H, clonality: BRIC110, decay accelerating factor to measure complement (Cromer blood group), sapiens, Complement Regulatory Protein |
| Alternative technique: |
murine |
| Alternative to gene target: |
CD55 and IDBG-106331 and ENSG00000196352 and 1604, CD55 and IDBG-629269 and ENSBTAG00000006984 and 518609, CR and CROM and DAF and TC, Extracellular, alpha-beta T cell activation and biological process this GO :2000563 and positive regulation of CD4-positive, alpha-beta T cell cytokine production and biological process this GO :0043086 and negative regulation of catalytic activity and biological process this GO :0043434 and response to peptide hormone and biological process this GO :0045087 and innate immune response and biological process this GO :0045121 and membrane raft and cellular component this GO :0045730 and respiratory burst and biological process this GO :0045916 and negative regulation of complement activation and biological process this GO :0060137 and maternal process involved in parturition and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :2000516 and positive regulation of CD4-positive, alpha-beta T cell proliferation and biological process, classical pathway and biological process this GO :0007204 and positive regulation of cytosolic calcium ion concentration and biological process this GO :0007283 and spermatogenesis and biological process this GO :0008289 and lipid binding and molecular function this GO :0009615 and response to virus and biological process this GO :0009986 and cell surface and cellular component this GO :0016324 and apical plasma membrane and cellular component this GO :0030449 and regulation of complement activation and biological process this GO :0031225 and anchored component of membrane and cellular component this GO :0031664 and regulation of lipopolysaccharide-mediated signaling pathway and biological process this GO :0035743 and CD4-positive, decay accelerating factor for complement (Cromer blood group), lipid binding, this GO :0001618 and virus receptor activity and molecular function this GO :0004857 and enzyme inhibitor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006958 and complement activation, this GO :0001618 : virus receptor activity, this GO :0001618 : virus receptor activity and also this GO :0004857 : enzyme inhibitor activity and also this GO :0005515 : protein binding and also this GO :0008289 : lipid binding, this GO :0004857 : enzyme inhibitor activity, this GO :0005515 : protein binding, this GO :0008289 : lipid binding, CD55 molecule |
| Identity: |
2665 |
| Gene: |
CD55 |
More about : CD55 |
| Long gene name: |
CD55 molecule (Cromer blood group) |
| Synonyms gene: |
DAF |
| Synonyms gene name: |
Cromer blood group system) CD55 molecule, decay accelerating factor for complement (CD55, decay accelerating factor for complement (Cromer blood group) |
| Synonyms: |
CR TC CROM |
| Locus: |
1q32, 2 |
| Discovery year: |
2001-06-22 |
| GenBank acession: |
BC001288 |
| Entrez gene record: |
1604 |
| RefSeq identity: |
NM_000574 |
| Classification: |
Sushi domain containing CD molecules Blood group antigens |
| Havana BLAST/BLAT: |
OTTHUMG00000036255 |
| Locus Specific Databases: |
Blood Group Antigen Mutation Database CD55base: Mutation registry for Decay-accelerating factor (CD55) deficiency (previously known as DAFbase) LRG_127 |